Lung adenocarcinoma large % of LUAD cases have no common driver mutation

KRAS
egfr 
nf1 truncation
braf
erbb2
met 
alk fusion
ros1 fusion
ret fusion
met amplififaciton
errbb2 amp
map2k1
nras
hras
rit1
fgfr2
fgfr1
others ~ 27.3%

lncrnas 

linc00261

patients with low linc00261 

kd of l261 -> increase prolif, migration, invasion

upgregulated dna repair pathway supported by accumuliation of cells in g2/m 

ectopic expression results in activation of DNA damage response proteins

?linc predict patient response to therapeutics



?linc related to total mutational burden

